Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 21, 2017

Non-HDL-cholesterol and C-reactive protein in children and adolescents with type 1 diabetes

María Mercedes Prado, Teresita Carrizo, Adela Victoria Abregú and Tomás Meroño

Abstract

Background:

To what extent high sensitivity C-reactive protein (hsCRP) is associated with known cardiovascular risk factors in children with type 1 diabetes (T1D) has not been fully explored.

Methods:

Forty-two T1D children (age: 12+/−1 years) without hypertension, retinopathy, hypothyroidism, albuminuria or other endocrine diseases and 20 controls were studied. Out of the 42 T1D patients studied 57% were prepubertal or early pubertal (Tanner I/II), 38% were pubertal (Tanner III/IV) and 5% post-pubertal (Tanner V).

Results:

Children with T1D showed higher hsCRP than controls [0.51 (0.31–1.71 vs. 0.20 (0.20–0.90) mg/L, p<0.05]. However, hsCRP levels were not different in subgroup analysis [hemoglobin A1c (HbA1c)>7.5% or disease duration>3 years] within the group of children with T1D. Conversely, non-high density lipoprotein (HDL)-cholesterol was different in the subgroup analysis. Moreover non-HDL-cholesterol was correlated with age (r=0.37, p<0.01), disease duration (r=0.36, p<0.01) and fasting glucose (r=0.55, p<0.0001).

Conclusions:

Non-HDL-cholesterol might be more useful than hsCRP to evaluate future cardiovascular risk in children with T1D.


Corresponding author: Dr. Tomás Meroño, Servicio de Bioquímica, Hospital Nacional “Prof. A. Posadas”, Av. Marconi y Pte. Illia s/n (1684), El Palomar, Buenos Aires, Argentina

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 2009;373:2027–33.10.1016/S0140-6736(09)60568-7Search in Google Scholar

2. Ce GV, Rohde LE, da Silva AM, Coutinho MK, de Castro AC, et al. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J Clin Endocrinol Metab 2011;96:1493–9.10.1210/jc.2010-2363Search in Google Scholar

3. Atabek ME, Pirgon O, Kurtoglu S, Imamoglu H. Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood. Pediatr Cardiol 2006;27:428–33.10.1007/s00246-006-1199-1Search in Google Scholar

4. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128(Suppl 5):S213–56.10.1542/peds.2009-2107CSearch in Google Scholar

5. Srinivasan SR, Frontini MG, Xu J, Berenson GS. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study. Pediatrics 2006;118:201–6.10.1542/peds.2005-1856Search in Google Scholar

6. Juonala M, Viikari JS, Ronnemaa T, Taittonen L, Marniemi J, et al. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2006;26:1883–8.10.1161/01.ATV.0000228818.11968.7aSearch in Google Scholar

7. Zhang Y, Jenkins AJ, Basu A, Stoner JA, Lopes-Virella MF, et al. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res 2016;57:310–7.10.1194/jlr.P060657Search in Google Scholar

8. Schwab KO, Doerfer J, Krebs A, Krebs K, Schorb E, et al. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr 2007;166:541–8.10.1007/s00431-007-0440-0Search in Google Scholar

9. Waris ME, Koskinen JO, Simell O, Knip M, Ilonen J. Onset of beta-cell autoimmunity is not associated with elevated concentration of C-reactive protein in children at genetic risk for type 1 diabetes. Diabet Med 2005;22:1123–4.10.1111/j.1464-5491.2005.01593.xSearch in Google Scholar

10. American Diabetes Association. 11. Children and adolescents. Diabetes Care 2016;39(Suppl 1):S86–93.10.2337/dc16-S014Search in Google Scholar

Received: 2016-8-2
Accepted: 2016-12-19
Published Online: 2017-2-21
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston